• 1:37:27 - 1:43:04
Nightmare Bombshell! Deaths Up 40% Among Those 18-64, Confirming Covid Vax Kills - FULL SHOW 1/4/22
The Clinical Benefits of Fluvoxamine and Prozac for COVID-19
Dr. Haider explains that Fluvoxamine and Prozac act on the sigma-1 receptor to provide anti-inflammatory and antiviral effects against COVID-19. He notes that while Johns Hopkins has included Fluvoxamine in its guidelines, the NIH and FDA have not. The segment highlights the work of Steve Kirsch in bankrolling clinical trials and the difficulty of finding pharmaceutical companies willing to support off-patent, low-cost treatments.